Is Amgen Stock a Buy? - Nasdaq

Apr 11, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amgen wasn’t one of them. The 10 stocks that made the cut ...

CouponFollow Extension

$153
OFF

Are Wall Street Analysts Predicting Amgen Stock Will Climb Or

2 weeks from now

3 days ago · With a market cap of $153.4 billion, Amgen Inc. (AMGN) is a global leader in biotechnology, focusing on innovative human therapeutics across various therapeutic areas …

nasdaq.com

05%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024 · While Amgen's (AMGN 0.05%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

$275.00
OFF

Amgen (NASDAQ:AMGN) Given New $275.00 Price Target At Bank …

2 weeks from now

1 day ago · The stock has a fifty day moving average of $271.14 and a 200 day moving average of $303.52. Amgen (NASDAQ:AMGN - Get Free Report) last posted its quarterly earnings …

marketbeat.com

37%
OFF

Is Amgen Still A Top Dividend Stock? - The Motley Fool

2 weeks from now

Dec 5, 2024 · History shows dividend stocks often outperform when the Fed pivots to rate cuts, setting up an interesting 2025 backdrop. Amgen's shares have slipped 3.37% in 2024 despite …

fool.com

4%
OFF

Amgen (AMGN) Gets A Buy From RBC Capital | Markets Insider

2 weeks from now

2 days ago · According to TipRanks, Renza has an average return of 10.4% and a 42.36% success rate on recommended stocks. In addition to RBC Capital, Amgen also received a Buy …

businessinsider.com

11%
OFF

Nancy A Grygiel Implements A Sell Strategy: Offloads $483K In …

2 weeks from now

23 hours ago · Amgen shares are trading down 0.11% at $297.45 at the time of this writing on Friday morning. Discovering Amgen: A Closer Look Amgen is a leader in biotechnology-based …

benzinga.com

4%
OFF

Earnings Miss? Amgen’s Dividend Still A Bright Spot - Nasdaq

2 weeks from now

2 days ago · Amgen Inc. (NASDAQ: AMGN) stock is down about 1.4% in after-hours trading despite beating estimates on the top and bottom lines in its fourth quarter 2024 earnings …

nasdaq.com

FAQs about Is Amgen Stock a Buy? - Nasdaq Coupon?

How much does Amgen stock cost?

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for Amgen is $314.00, with a high forecast of $405.00 and a low forecast of $195.00. Should I buy or sell Amgen stock right now? ...

Should you buy Amgen (AMGN)?

27 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last twelve months. There are currently 2 sell ratings, 12 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMGN shares. ...

Where can I find Amgen Inc (AMGN) stock information?

Register for your free account today at data.nasdaq.com. Discover real-time Amgen Inc. Common Stock (AMGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. ...

Is Amgen Inc (AMGN) a good dividend stock?

Amgen Inc. (NASDAQ:AMGN) currently pays a quarterly dividend of $2.38 per share, having raised it by 5.8% in December 2024. Through this increase, the company stretched its dividend growth streak to 13 years, which makes AMGN one of the best dividend stocks on our list. The stock’s dividend yield came in at 3.53%, as of January 15. ...

What is the price target for Amgen (AMGN)?

The highest price target for AMGN is $405.00, while the lowest price target for AMGN is $195.00. The average price target represents a forecasted upside of 8.70% from the current price of $288.87. Enter your email address to receive the latest news and analysts' ratings for Amgen and its competitors. ...

Is Amgen a good stock to buy in 2025?

When the Federal Reserve signals a shift toward monetary easing, investors often rotate toward stable, high-yielding equities that can provide both income and potential appreciation. Amgen (AMGN 0.49%) offers an intriguing test case for this dynamic heading into 2025. ...